Parallel evolution under chemotherapy pressure in 29 breast cancer cell lines results in dissimilar mechanisms of resistance.

por Bálint Tegze, Zoltán Szállási, Irén Haltrich, Zsófia Pénzváltó, Zsuzsa Tóth, István Likó, Balázs Gyorffy
Publicado 2012

Quantification of within-sample genetic heterogeneity from SNP-array data

por Pierre Martinez, Christopher Kimberley, Nicolai J. BirkBak, Andrea Marquard, Zoltan Szallasi, Trevor A. Graham
Publicado 2017

A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures

por Miklos Diossy, Zsofia Sztupinszki, Judit Borcsok, Marcin Krzystanek, Viktoria Tisza, Sandor Spisak, Orsolya Rusz, Jozsef Timar, István Csabai, Janos Fillinger, Judit Moldvay, Anders Gorm Pedersen, David Szuts, Zoltan Szallasi
Publicado 2021

Tumor mutation burden forecasts outcome in ovarian cancer with BRCA1 or BRCA2 mutations.

por Nicolai Juul Birkbak, Bose Kochupurakkal, Jose M G Izarzugaza, Aron C Eklund, Yang Li, Joyce Liu, Zoltan Szallasi, Ursula A Matulonis, Andrea L Richardson, J Dirk Iglehart, Zhigang C Wang
Publicado 2013

Human endogenous retroviruses form a reservoir of T cell targets in hematological cancers

por Sunil Kumar Saini, Andreas Due Ørskov, Anne-Mette Bjerregaard, Ashwin Unnikrishnan, Staffan Holmberg-Thydén, Annie Borch, Kathrine Valentini Jensen, Govardhan Anande, Amalie Kai Bentzen, Andrea Marion Marquard, Tripti Tamhane, Marianne Bach Treppendahl, Anne Ortved Gang, Inge Høgh Dufva, Zoltan Szallasi, Nicola Ternette, Anders Gorm Pedersen, Aron Charles Eklund, John Pimanda, Kirsten Grønbæk, Sine Reker Hadrup
Publicado 2020